1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ksq-001Ex Cancer	M.D. Anderson Cancer Center	P1/2	CC (40)
lat010 Cancer	Latticon Antibody Therapeutics, Inc	P1/2	CC (40)
lb101 Cancer	Centessa Pharmaceuticals (UK) Limited	P1/2	CC (40)
lcb84 Cancer	LigaChem Biosciences, Inc.	P1/2	CC (40)
lm-2417 Cancer	LaNova Medicines Limited	P1/2	CC (40)
lm-24c5 Cancer	LaNova Medicines Limited	P1/2	CC (40)
Luvixasertib Cancer	Treadwell Therapeutics, Inc	P1/2	CC (40)
Mage-A1-Specific T Cell Receptor-Transduced Autologous T-Cells Cancer	T-knife GmbH	P1/2	CC (40)
mb0151 for Cancer	Mainline Biosciences (Shanghai) Co., Ltd	P1/2	CC (40)
Mbf-362 Cancer	Medibiofarma S.L.	P1	CC (40)
Mdna11 Cancer	Medicenna Therapeutics, Inc.	P1/2	CC (40)
mhb036c Cancer	Minghui Pharmaceutical (Hangzhou) Ltd	P1/2	CC (40)
mhb039a Cancer	Minghui Pharmaceutical (Hangzhou) Ltd	P1/2	CC (40)
mk-1088 Cancer	Merck Sharp & Dohme LLC	P1/2	CC (40)
mk-3120 Cancer	Merck Sharp & Dohme LLC	P1/2	CC (40)
Monalizumab Cancer	MedImmune LLC	P1/2	CC (40)
mrg006a Cancer	Lepu Biopharma Co., Ltd.	P1/2	CC (40)
Mrna-4359 Cancer	ModernaTX, Inc.	P1/2	CC (40)
Nemvaleukin Alfa Cancer	Mural Oncology, Inc	P1/2	CC (40)
nts071 Cancer	Nutshell Therapeutics (Shanghai) Co., LTD.	P1/2	CC (40)
Ntx-301 Cancer	Xennials Therapeutics Australia Pty Ltd	P1/2	CC (40)
Nuv-1511 Cancer	Nuvation Bio Inc.	P1/2	CC (40)
Obi 3424 Cancer	Ascentawits Pharmaceuticals, Ltd	P1/2	CC (40)
Obi-902 Cancer	OBI Pharma, Inc	P1/2	CC (40)
Obi-992 Cancer	OBI Pharma, Inc	P1/2	CC (40)
Otp-01 Cancer	Ottimo Pharma Limited	P1/2	CC (40)
Paroxetine Cancer	BioNTech SE	P1/2	CC (40)
pm1003 Cancer	Biotheus Inc.	P1/2	CC (40)
Ptt-4256 Cancer	Pathios Therapeutics Pty Ltd	P1/2	CC (40)
Pulocimab Cancer	Akeso	P1/2	CC (40)
Pumitamig Cancer	BioNTech SE	P1/2	CC (40)
Purinostat Cancer	Chengdu Zenitar Biomedical Technology Co., Ltd	P1/2	CC (40)
Pyrotinib Cancer	Risen (Suzhou) Pharma Tech Co., Ltd.	P1/2	CC (40)
ql2107 Cancer	Qilu Pharmaceutical Co., Ltd.	P1/2	CC (40)
qlc5508 Cancer	Qilu Pharmaceutical Co., Ltd.	P1/2	CC (40)
rc118 Cancer	RemeGen Co., Ltd.	P1/2	CC (40)
rc118-adc Cancer	RemeGen Co., Ltd.	P1/2	CC (40)
rc148 Cancer	RemeGen Co., Ltd.	P1/2	CC (40)
Regn10597 Cancer	Regeneron Pharmaceuticals	P1/2	CC (40)
RNK05047 Cancer	Ranok Therapeutics (Hangzhou) Co., Ltd.	P1/2	CC (40)
Ropidoxuridine Cancer	National Cancer Institute (NCI)	P1	CC (40)
Salmonella Enterica Subsp. Enterica Serovar Typhimurium Which Comprises A Methioninase Gene Cancer	Guangzhou Sinogen Pharmaceutical Co., Ltd	P1/2	CC (40)
Selumetinib Cancer	Cancer Research UK	P1	CC (40)
sg001 Cancer	Shanghai Runshi Pharmaceutical Technology Co., Ltd	P1/2	CC (40)
Shr-3276 Cancer	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1/2	CC (40)
Shr-4375 Cancer	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1/2	CC (40)
Shr-4642 Cancer	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1/2	CC (40)
Shr-7787 Cancer	Shanghai Hengrui Pharmaceutical Co., Ltd.	P1/2	CC (40)
Shr-8068 Cancer	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1/2	CC (40)
Shr-9839 For Cancer	Shanghai Hengrui Pharmaceutical Co., Ltd.	P1/2	CC (40)

Showing 651 to 700 of 1,379 assets

PreviousPage 14 of 28Next